跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
胡 書維
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0003-4382-5523
電子郵件
10352
s.tmu.edu
tw
h-index
69
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2017
2024
每年研究成果
概覽
指紋
網路
研究成果
(16)
類似的個人檔案
(6)
指紋
查看啟用 Su-Wei Hu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Treatment Response
100%
Prostate Cancer
84%
Percutaneous Nephrolithotomy
84%
Recurrent Disease
70%
Metastatic Carcinoma
62%
Injury
61%
Disease
57%
Urolithiasis
56%
Operation Duration
52%
Upregulation
48%
Phosphodiesterase V Inhibitor
48%
Erectile Dysfunction
47%
Mediator Complex
42%
Randomized Clinical Trial
42%
Dilation Procedure
42%
Systematic Review
42%
Neobladder
42%
Meta-Analysis
42%
Urinary System
42%
Genitourinary System
42%
Extracorporeal Shock Wave Lithotripsy
42%
Hernioplasty
42%
Extracorporeal Shockwave Therapy
42%
Urethra Stenosis
42%
Urethrotomy
42%
Microhematuria
42%
Transitional Cell Carcinoma
42%
Neoplasm
42%
Surgical Anastomosis
42%
Hemostat
42%
Castration Resistant Prostate Cancer
42%
Isotopes of Calcium
42%
Extracorporeal
42%
Carcinogenicity
42%
Cystectomy
42%
Focal Segmental Glomerulosclerosis
42%
Symptom
42%
Vardenafil
42%
Cell Damage
42%
Acute Kidney Injury
42%
Growth Differentiation Factor 15
42%
Postoperative Pain
40%
In Vitro
36%
Disease Exacerbation
35%
Stent Placement
31%
Testosterone Metabolism
31%
Fluoroscopy
28%
Androgen
27%
Malignant Neoplasm
23%
Biochemical Recurrence
21%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
84%
Recurrent Disease
67%
Disease
51%
Androgen
48%
Disease Exacerbation
46%
Mouse Model
45%
Mediator Complex
42%
Chronic Prostatitis
42%
Focal Glomerulosclerosis
42%
Phosphodiesterase V Inhibitor
42%
Pelvis Pain Syndrome
42%
Vardenafil
42%
Castration Resistant Prostate Cancer
42%
Carcinogenicity
42%
Biochemical Recurrence
42%
Transitional Cell Carcinoma
42%
Neoplasm
42%
Hernia
42%
Growth Differentiation Factor 15
42%
Acute Kidney Failure
42%
Malignant Neoplasm
33%
Tamsulosin
30%
Postoperative Pain
25%
Multidrug Resistance Protein 1
21%
Overall Survival
21%
Docetaxel
21%
Kruppel Like Factor 4
21%
Dutasteride
21%
ABCC1
21%
Drug Resistance
21%
Retrospective Study
16%
Prospective Study
16%
Surgical Infection
16%
Randomized Controlled Trial
16%
Hematoma
16%
Seroma
16%
Bladder Cancer
16%
Doxorubicin
15%
Short Hairpin RNA
12%
Therapy Resistance
12%
Therapeutic Effect
10%
Symptom
10%
Biological Marker
10%
Metastasis
9%
Hemoperitoneum
8%
Inguinal Hernia
8%
Laceration
8%
Femoral Hernia
8%
Recurrence Risk
8%
Random Effects Model
8%
Biochemistry, Genetics and Molecular Biology
Upregulation
47%
Mediator Complex
42%
Promoter Region
42%
Genetics
42%
SRD5A1
42%
Interleukin 8
42%
Interleukin 6
42%
Growth Differentiation Factor
42%
Cell Damage
42%
Genetic Model
25%
Allele
16%
Inflammatory Cytokine
14%
Testosterone Metabolism
14%
down Regulation
11%
Small Hairpin RNA
10%
Transcription
9%
Drive
8%
Cell Proliferation
8%
Cochrane Library
8%
Embase
8%
Web of Science
8%
Medline
8%
Mediator
7%
Gene Expression Profiling
7%
Case-Control Study
6%
Sample Size
6%
Enzalutamide
5%
SNAI2
5%
Cell Migration
5%
